001     164278
005     20240229123209.0
024 7 _ |a 10.3389/fonc.2020.541281
|2 doi
024 7 _ |a altmetric:92889845
|2 altmetric
037 _ _ |a DKFZ-2020-02361
082 _ _ |a 610
100 1 _ |a Massi, Michela Carlotta
|b 0
245 _ _ |a A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
260 _ _ |a Lausanne
|c 2020
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1604586623_2353
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Gasperoni, Francesca
|b 1
700 1 _ |a Ieva, Francesca
|b 2
700 1 _ |a Paganoni, Anna Maria
|b 3
700 1 _ |a Zunino, Paolo
|b 4
700 1 _ |a Manzoni, Andrea
|b 5
700 1 _ |a Franco, Nicola Rares
|b 6
700 1 _ |a Veldeman, Liv
|b 7
700 1 _ |a Ost, Piet
|b 8
700 1 _ |a Fonteyne, Valérie
|b 9
700 1 _ |a Talbot, Christopher J.
|b 10
700 1 _ |a Rattay, Tim
|b 11
700 1 _ |a Webb, Adam
|b 12
700 1 _ |a Symonds, Paul R.
|b 13
700 1 _ |a Johnson, Kerstie
|b 14
700 1 _ |a Lambrecht, Maarten
|b 15
700 1 _ |a Haustermans, Karin
|b 16
700 1 _ |a De Meerleer, Gert
|b 17
700 1 _ |a de Ruysscher, Dirk
|b 18
700 1 _ |a Vanneste, Ben
|b 19
700 1 _ |a Van Limbergen, Evert
|b 20
700 1 _ |a Choudhury, Ananya
|b 21
700 1 _ |a Elliott, Rebecca M.
|b 22
700 1 _ |a Sperk, Elena
|b 23
700 1 _ |a Herskind, Carsten
|b 24
700 1 _ |a Veldwijk, Marlon R.
|b 25
700 1 _ |a Avuzzi, Barbara
|b 26
700 1 _ |a Giandini, Tommaso
|b 27
700 1 _ |a Valdagni, Riccardo
|b 28
700 1 _ |a Cicchetti, Alessandro
|b 29
700 1 _ |a Azria, David
|b 30
700 1 _ |a Jacquet, Marie-Pierre Farcy
|b 31
700 1 _ |a Rosenstein, Barry S.
|b 32
700 1 _ |a Stock, Richard G.
|b 33
700 1 _ |a Collado, Kayla
|b 34
700 1 _ |a Vega, Ana
|b 35
700 1 _ |a Aguado-Barrera, Miguel Elías
|b 36
700 1 _ |a Calvo, Patricia
|b 37
700 1 _ |a Dunning, Alison M.
|b 38
700 1 _ |a Fachal, Laura
|b 39
700 1 _ |a Kerns, Sarah L.
|b 40
700 1 _ |a Payne, Debbie
|b 41
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 42
|u dkfz
700 1 _ |a Seibold, Petra
|0 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215
|b 43
|u dkfz
700 1 _ |a West, Catharine M. L.
|b 44
700 1 _ |a Rancati, Tiziana
|b 45
773 _ _ |a 10.3389/fonc.2020.541281
|g Vol. 10, p. 541281
|0 PERI:(DE-600)2649216-7
|p 541281
|t Frontiers in oncology
|v 10
|y 2020
|x 2234-943X
909 C O |o oai:inrepo02.dkfz.de:164278
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 42
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 43
|6 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT ONCOL : 2018
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-01-05
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2020-01-05
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-05
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-01-05
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|f 2020-01-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-01-05
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21